ESR1 and breast cancer: While therapeutic targets such as Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesteron Receptor (PR) have improved treatment strategies for certain BC subtypes, further research is needed to identify additional molecular players involved in cancer progression.